Familial Analysis of Keratoconus Risk (AFRIK)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02812563|
Recruitment Status : Completed
First Posted : June 24, 2016
Last Update Posted : November 13, 2017
The principal objective of this study is to evaluate the frequency of KC inside family of patients with confirmed KC.
It's a familial, epidemiological, prospective, single-center study.
|Condition or disease||Intervention/treatment|
Keratoconus is a common bilateral progressive corneal ectatic disease causing visual impairment by inducing irregular astigmatism and corneal opacities. This disorder typically begins during teenage years, progresses until the age of 30 to 40 years and, in severe forms, may need a corneal transplantation.
Currently, keratoconus has not known etiopathogenesis, and it is difficult to detect subclinical forms.
Several risk factors seem to be implied, environmental and genetic : the risk of keratoconus in case of familial history of keratoconus isn't well known at that time, but seems to be important to consider to promote screening and follow up of patient with a familial history of keratoconus (KC).
|Study Type :||Observational|
|Actual Enrollment :||95 participants|
|Official Title:||Familial Analysis of Keratoconus Risk|
|Actual Study Start Date :||November 25, 2014|
|Actual Primary Completion Date :||September 19, 2017|
|Actual Study Completion Date :||September 19, 2017|
- Other: genetic
Galilee exam - Corn analysis with Optiwave Refractive Analysis
- proportion of diagnosed keratoconus [ Time Frame: 1 day ]
- Assesment of familial history on KC severity [ Time Frame: 1 day ]
- Evaluation of KC severity [ Time Frame: 1 day ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02812563
|Centre de Référence National du Kératocône Service d'ophtalmologie - Hôpital Pellegrin|
|Bordeaux, France, 33000|
|Principal Investigator:||David Touboul, MD||University Hospital Bordeaux, France|